Join        Login             Stock Quote

U.S. Stocks Plunge, Alcoa In Focus; Hot Stocks: AA, SVU, BBY, VPHM, OPTR, PVR, XRIT

 April 10, 2012 04:19 PM

U.S. stocks retreated sharply ahead of the beginning of first-quarter earnings season even as fresh worries on European debt crisis dented the sentiment.

S&P 500 Index lost 1.71 percent to finish at 1,358.59. The Dow Jones Industrial Average dropped 1.65 percent to end at 12,715.93. The Nasdaq Composite Index closed at 2,991.22, down 1.83 percent.

On the economic front, wholesale inventories at the end of February rose more than forecast. A report from the Commerce Department showed that inventories advanced 0.9 percent from the previous month, while economists expected a 0.5 percent rise.

Hot Stocks Of The Day: (AA, SVU, BBY, VPHM, OPTR, PVR, XRIT)

In corporate news, Alcoa Inc. (NYSE:AA) jumped 4.19 percent to $9.70 in extended trading after the aluminum maker posted a surprise quarterly profit. On an adjusted basis, the company earned 10 cents a share on sales of $6.0 billion. Analysts' expected a loss of 4 cents a share on sales of $5.8 billion for the first quarter. Alcoa still expects a global aluminum supply deficit in 2012 and reaffirmed its forecast that global aluminum demand would grow 7 percent in 2012.

[Related -Do Earnings Mean Anything Anymore?]

Supervalu Inc. (NYSE:SVU) surged 15 percent after the grocery retailer guided 2013 EPS above Wall Street projections. It sees fiscal 2013 EPS in the range of $1.27 to $1.42, while analysts expect $1.19 a share.

[Related -Alcoa Inc (NYSE:AA) Q4 Earnings Preview: What To Expect?]

Best Buy Co. Inc. (NYSE:BBY) reversed earlier gains to close 5.8 percent lower. The retailer of consumer electronics said Brian Dunn has resigned as chief executive officer and it named director Mike Mikan as the interim CEO.

X-Rite Inc. (Nasdaq:XRIT) soared 38.50 percent after the provider of color management systems agreed to be bought by Danaher Corp. (NYSE: DHR) for $5.55 per share, a 39 percent premium to X-Rite's closing share price of $4.00 on Monday.

Viropharma Inc. (Nasdaq:VPHM) plunged 21.5 percent after the U.S. Food and Drug Administration indicated that it is approving three generic version of ViroPharma's vancomycin capsules. In addition, the company has received a notification that the Federal Trade Commission is conducting an investigation into whether the company has engaged in unfair methods of competition with respect to Vancocin.

Optimer Pharmaceuticals Inc.

Next Page >>12
iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageLong-term Relationships and Credit Scores

Unlike many commentators, I tend to think credit scores are a good read on...

article imageIn Defense Of Rolling Return Charts

Robeco’s Lukas Daalder has a bit of an issue with rolling-performance graphics. Bashing a recent chart of read on...

article imageThe S&P 500’s Worrisome Downturn In Drawdown

Last Friday I reviewed some of the bearish signals that were casting dark shadows across the US stock read on...

article imageADP: Private-Sector Employment Rises A Solid 200k In September

The pace of growth for private-sector employment picked up in September, according to this morning’s ADP read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.